CDK4 and breast cancer: High mRNA expression levels of CDK4 in eVs, analyzed in baseline plasma samples from 40 HR-positive/HER2-negative advanced BC patients receiving palbociclib plus endocrine therapy correlated significantly with a longer PFS [330].